DK1635692T3 - Monitorering af immunologiske, hematologiske og inflammatoriske sygdomme - Google Patents

Monitorering af immunologiske, hematologiske og inflammatoriske sygdomme

Info

Publication number
DK1635692T3
DK1635692T3 DK04776460.0T DK04776460T DK1635692T3 DK 1635692 T3 DK1635692 T3 DK 1635692T3 DK 04776460 T DK04776460 T DK 04776460T DK 1635692 T3 DK1635692 T3 DK 1635692T3
Authority
DK
Denmark
Prior art keywords
monitoring
inflammatory diseases
hematological
immunological
conditions
Prior art date
Application number
DK04776460.0T
Other languages
English (en)
Inventor
Joseph M Ahearn
Susan M Manzi
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Application granted granted Critical
Publication of DK1635692T3 publication Critical patent/DK1635692T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/14—Devices for taking samples of blood ; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
DK04776460.0T 2003-06-13 2004-06-12 Monitorering af immunologiske, hematologiske og inflammatoriske sygdomme DK1635692T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47849303P 2003-06-13 2003-06-13
PCT/US2004/018552 WO2004112572A2 (en) 2003-06-13 2004-06-12 Monitoring immunologic, hematologic and inflammatory diseases

Publications (1)

Publication Number Publication Date
DK1635692T3 true DK1635692T3 (da) 2010-08-09

Family

ID=33539102

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04776460.0T DK1635692T3 (da) 2003-06-13 2004-06-12 Monitorering af immunologiske, hematologiske og inflammatoriske sygdomme

Country Status (14)

Country Link
US (1) US8080382B2 (da)
EP (2) EP2194383A1 (da)
JP (2) JP2007501948A (da)
KR (1) KR20060015646A (da)
AT (1) ATE465275T1 (da)
AU (1) AU2004249155B2 (da)
CA (1) CA2529045A1 (da)
DE (1) DE602004026724D1 (da)
DK (1) DK1635692T3 (da)
ES (1) ES2342291T3 (da)
IL (1) IL172488A0 (da)
NO (1) NO20056013L (da)
WO (1) WO2004112572A2 (da)
ZA (1) ZA200510325B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002323691C1 (en) * 2001-09-10 2009-03-05 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Diagnosis and monitoring of systemic lupus erythematosus and of scleroderma
WO2004093647A2 (en) 2003-04-16 2004-11-04 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Identification and monitoring of systematic lupus erythematosus
ATE478335T1 (de) * 2004-04-09 2010-09-15 Univ Pittsburgh Verfahren in echtzeit zur erkennung von akuten entzündungszuständen
JP2007537449A (ja) * 2004-05-11 2007-12-20 ユニバーシティ オブ ピッツバーグ 白血球上の補体成分を測定することによる炎症性疾患の診断およびモニタリング
JP2009509169A (ja) * 2005-09-19 2009-03-05 ザ・ジョンズ・ホプキンス・ユニバーシティ 前立腺癌のためのバイオマーカー
WO2007095154A2 (en) * 2006-02-10 2007-08-23 The Brigham And Women's Hospital, Inc. Lectin complement pathway assays and related compositions and methods
FR2899337B1 (fr) * 2006-03-31 2008-07-04 Univ Reims Champagne Ardenne Standard c4d / c4b pour cytometrie de flux quantitative du rejet humoral de transplantation.
US7824874B2 (en) * 2006-05-25 2010-11-02 Litron Laboratories, Ltd. Method for measuring in vivo mutation frequency at an endogenous gene locus
WO2009111577A1 (en) * 2008-03-04 2009-09-11 California Institute Of Technology Methods of using optofluidic microscope devices
US8039776B2 (en) 2008-05-05 2011-10-18 California Institute Of Technology Quantitative differential interference contrast (DIC) microscopy and photography based on wavefront sensors
US8187826B2 (en) * 2008-06-12 2012-05-29 Litron Laboratories, Ltd. Quantitative analysis of in vivo mutation at the Pig-A locus
WO2010045611A2 (en) * 2008-10-16 2010-04-22 Cypress Bioscience, Inc. Method for diagnosis and monitoring of disease activity and response to treatment in systemic lupus erythematosus (sle) and other autoimmune diseases
CN102292662A (zh) 2009-01-21 2011-12-21 加州理工学院 用于计算深度切片的定量微分干涉差（dic）设备
US8416400B2 (en) 2009-06-03 2013-04-09 California Institute Of Technology Wavefront imaging sensor
KR101029004B1 (ko) * 2009-08-06 2011-04-14 강원대학교산학협력단 염증성 관절염 마커로서의 ｐｒｄｍ10 단백질 및 이를 포함하는 염증성 관절염 진단키트
EP2550522B1 (en) 2010-03-23 2016-11-02 California Institute of Technology Super resolution optofluidic microscopes for 2d and 3d imaging
ES2564290T3 (es) 2010-11-02 2016-03-21 Kypha, Inc. Inmunoensayo de flujo lateral para la activación de complemento y métodos de uso para evaluación del sitio de atención de trastornos asociados a complemento
EP2643694B1 (en) 2010-11-24 2018-01-03 Litron Laboratories Ltd. Rapid in vivo gene mutation assay based on the pig-a gene
EP2646821A4 (en) 2010-11-29 2015-09-23 Novelmed Therapeutics Inc NEOANTIC BODY FOR THE DIAGNOSIS OF TISSUE INJURY
WO2012109592A1 (en) 2011-02-11 2012-08-16 Exagen Diagnostics, Inc. Methods for diagnosing systemic lupus erythematosus
JP5867834B2 (ja) * 2011-09-15 2016-02-24 株式会社島津製作所 肺癌マーカー補体Ｃ３ｄｇ分子及び肺癌マーカーの分析方法
WO2013143940A1 (en) * 2012-03-29 2013-10-03 Proyecto De Biomedicina Cima, S.L. New lung cancer molecular markers
WO2013155460A1 (en) * 2012-04-13 2013-10-17 Somalogic, Inc. Tuberculosis biomarkers and uses thereof
EP2866821B1 (en) 2012-07-02 2018-11-14 Medizinische Universität Wien Complement split product c4d for the treatment of inflammatory conditions
US10413620B2 (en) 2012-08-17 2019-09-17 The Regents Of The University Of Colorado, A Body Corporate Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
AU2013302441B2 (en) * 2012-08-17 2018-05-10 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for detecting complement activation
RU2019103573A (ru) 2013-02-08 2019-03-15 Аллегени-Сингер Рисерч Инститьют Клеточно-связанные продукты активации комплемента в качестве диагностических биомаркеров волчанки в доклинической стадии
US9863946B2 (en) 2013-02-08 2018-01-09 Allegheny-Singer Research Institute Cell-bound complement activation products as diagnostic biomarkers for pre-lupus
EP2972365B1 (en) 2013-03-15 2019-11-20 Exagen Diagnostics, Inc. Methods for treating and diagnosing systemic lupus erythematosus
US20140335546A1 (en) * 2013-05-10 2014-11-13 G J Carroll Pty Ltd Devices and Methods for Determining the Risk of Developing a Serious Infection
JP6170865B2 (ja) 2014-03-31 2017-07-26 シスメックス株式会社 血液分析装置
US10206632B2 (en) * 2014-07-25 2019-02-19 The Trustees Of Dartmouth College Systems and methods for cardiovascular-dynamics correlated imaging
WO2016040314A1 (en) * 2014-09-08 2016-03-17 Yale University Compositions and methods for increasing red blood cells
EP3329278A4 (en) 2015-07-31 2019-01-16 Allegheny-Singer Research Institute CELL COMPLEMENT ACTIVATION ACTIVITY ASSAYS AS AUXILIARY DIAGNOSIS FOR ANTIBODY-BASED MEDICINES
BR112019009495A2 (pt) * 2016-12-09 2019-08-06 Gliknik Inc métodos de tratamento de distúrbios inflamatórios com compostos de fc multivalentes
EP3361256A1 (en) * 2017-02-08 2018-08-15 Fundación para la Investigación Médica Aplicada In vitro method for the diagnosis of lung cancer
EP3771468A1 (en) * 2019-07-31 2021-02-03 Universitätsklinikum Hamburg-Eppendorf C3/c5 convertase assays

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
DE69029036T2 (de) 1989-06-29 1997-05-22 Medarex Inc Bispezifische reagenzien für die aids-therapie
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
JPH06507398A (ja) 1991-05-14 1994-08-25 リプリジェン　コーポレーション Ｈｉｖ感染治療のための異種複合抗体
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
EP0666987A4 (en) 1992-10-30 1997-08-27 T Cell Diagnostics Inc EVALUATION OF THE TOTAL QUANTITY OF A MOLECULE IN A SAMPLE AND METHODS BASED ON SAME.
AU2002323691C1 (en) 2001-09-10 2009-03-05 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Diagnosis and monitoring of systemic lupus erythematosus and of scleroderma
WO2004093647A2 (en) 2003-04-16 2004-11-04 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Identification and monitoring of systematic lupus erythematosus

Also Published As

Publication number Publication date
DE602004026724D1 (de) 2010-06-02
AU2004249155A1 (en) 2004-12-29
ZA200510325B (en) 2008-04-30
AU2004249155B2 (en) 2009-11-19
KR20060015646A (ko) 2006-02-17
WO2004112572A2 (en) 2004-12-29
EP2194383A1 (en) 2010-06-09
US8080382B2 (en) 2011-12-20
EP1635692A2 (en) 2006-03-22
ES2342291T3 (es) 2010-07-05
IL172488A0 (en) 2006-04-10
EP1635692A4 (en) 2007-12-05
WO2004112572A3 (en) 2005-06-02
JP2007501948A (ja) 2007-02-01
NO20056013L (no) 2006-03-10
ATE465275T1 (de) 2010-05-15
EP1635692B1 (en) 2010-04-21
JP2010164581A (ja) 2010-07-29
US20050042602A1 (en) 2005-02-24
CA2529045A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
DK1635692T3 (da) Monitorering af immunologiske, hematologiske og inflammatoriske sygdomme
DK1745287T3 (da) Diagnostisering og monitorering af inflammatoriske sygdomme ved at måle komplementkomponenter på hvide blodlegemer
DK2021796T3 (da) Diagnose af hjerte-kar-sygdom
PL1836500T3 (pl) Sposoby i testy do rozróżniania między różnymi postaciami chorób i zaburzeń cechujących się małopłytkowością i/lub samoistną interakcją między czynnikiem von Willebranda (vWF) a płytkami krwi
EA200500143A1 (ru) Азолидинонвинильные производные конденсированного бензола
WO2005103281A3 (en) Platelet biomarkers for the detection of disease
SE0400191D0 (sv) A test kit for detecting periodontal disease
ATE498134T1 (de) Nachweis von staphylococcus
GB0512401D0 (en) Method
NO20052992D0 (no) Markorproteiner for diagnostisering av leversykdom og fremgangsmate for diagnostisering av leversykdom.
Iversen et al. Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia
EP2322646A8 (en) Method of detecting platelet thrombosis or organ failure
DE60234821D1 (de) Messverfahren für vollblut
FI20031370A0 (fi) Automaattinen hemoglobiinin määritysmenetelmä vastasyntyneiden seulontaan
MX2009003576A (es) Compuestos anticoagulantes.
Sthoeger et al. Transient anticardiolipin antibodies, functional protein S deficiency, and deep vein thrombosis
BR0317404A (pt) Variantes do fator xiia
DE60310655D1 (de) Kombination von CRP und D-Dimer zur Diagnose von tiefer Venenthrombose
FI20010868A0 (fi) Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi
WO2007075641A3 (en) Methods for assessing the pro-inflammatory immune health of an individual
EA200600657A1 (ru) Новая комбинация антиатеротромботического средства и средства, предотвращающего агрегацию тромбоцитов
RU2002133200A (ru) Способ оценки состояния системы гемокоагуляции при дессиминированном внутрисосудистом свертывании крови
WO2006055973A3 (en) Erythropoietin for treatment of multi-organ failure
WO2007075601A3 (en) Methods for assessing the pro-inflammatory immune health of an individual
RU2195676C2 (ru) Способ комплексной оценки прогноза эффективности лечения диффузных заболеваний соединительной ткани низкомолекулярными антикоагулянтами